318 related articles for article (PubMed ID: 31126309)
1. Interleukin-32θ inhibits tumor-promoting effects of macrophage-secreted CCL18 in breast cancer.
Pham TH; Bak Y; Kwon T; Kwon SB; Oh JW; Park JH; Choi YK; Hong JT; Yoon DY
Cell Commun Signal; 2019 May; 17(1):53. PubMed ID: 31126309
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of IL-13 and IL-13Rα2 Expression by IL-32θ in Human Monocytic Cells Requires PKCδ and STAT3 Association.
Pham TH; Bak Y; Oh JW; Hong J; Lee S; Hong JT; Yoon DY
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31010051
[TBL] [Abstract][Full Text] [Related]
3. Modulatory effects of point-mutated IL-32θ (A94V) on tumor progression in triple-negative breast cancer cells.
Park HM; Park JY; Kim NY; Kim J; Pham TH; Hong JT; Yoon DY
Biofactors; 2024; 50(2):294-310. PubMed ID: 37658685
[TBL] [Abstract][Full Text] [Related]
4. IL-32θ inhibits stemness and epithelial-mesenchymal transition of cancer stem cells via the STAT3 pathway in colon cancer.
Bak Y; Kwon T; Bak IS; Hong J; Yu DY; Yoon DY
Oncotarget; 2016 Feb; 7(6):7307-17. PubMed ID: 26824417
[TBL] [Abstract][Full Text] [Related]
5. IL-32θ downregulates CCL5 expression through its interaction with PKCδ and STAT3.
Bak Y; Kang JW; Kim MS; Park YS; Kwon T; Kim S; Hong J; Yoon DY
Cell Signal; 2014 Dec; 26(12):3007-15. PubMed ID: 25280942
[TBL] [Abstract][Full Text] [Related]
6. Nir1 promotes invasion of breast cancer cells by binding to chemokine (C-C motif) ligand 18 through the PI3K/Akt/GSK3β/Snail signalling pathway.
Zhang B; Yin C; Li H; Shi L; Liu N; Sun Y; Lu S; Liu Y; Sun L; Li X; Chen W; Qi Y
Eur J Cancer; 2013 Dec; 49(18):3900-13. PubMed ID: 24001613
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-32θ Triggers Cellular Senescence and Reduces Sensitivity to Doxorubicin-Mediated Cytotoxicity in MDA-MB-231 Cells.
Pham TH; Park HM; Kim J; Hong JT; Yoon DY
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34067074
[TBL] [Abstract][Full Text] [Related]
8. CXCL1 derived from tumor-associated macrophages promotes breast cancer metastasis via activating NF-κB/SOX4 signaling.
Wang N; Liu W; Zheng Y; Wang S; Yang B; Li M; Song J; Zhang F; Zhang X; Wang Q; Wang Z
Cell Death Dis; 2018 Aug; 9(9):880. PubMed ID: 30158589
[TBL] [Abstract][Full Text] [Related]
9. CCL18 from tumor-associated macrophages promotes angiogenesis in breast cancer.
Lin L; Chen YS; Yao YD; Chen JQ; Chen JN; Huang SY; Zeng YJ; Yao HR; Zeng SH; Fu YS; Song EW
Oncotarget; 2015 Oct; 6(33):34758-73. PubMed ID: 26416449
[TBL] [Abstract][Full Text] [Related]
10. IL-32θ inhibits monocytic differentiation of leukemia cells by attenuating expression of transcription factor PU.1.
Kim MS; Kang JW; Park YS; Lee DH; Bak Y; Kwon T; Yoon DY
Oncotarget; 2015 Feb; 6(6):4394-405. PubMed ID: 25726525
[TBL] [Abstract][Full Text] [Related]
11. [Molecular mechanism of macrophages derived from PGRN gene knockout mice inhibit invasion and migration of breast cancer cells].
Yue S; Gan D; Qian H; Zhou T; Zhang D; Shi H; Fang W; Yao M; Chen T
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Sep; 35(9):769-775. PubMed ID: 31750816
[TBL] [Abstract][Full Text] [Related]
12. Discovery of CCL18 antagonist blocking breast cancer metastasis.
Liu Y; Zheng H; Li Q; Li S; Lai H; Song E; Li D; Chen J
Clin Exp Metastasis; 2019 Jun; 36(3):243-255. PubMed ID: 31062206
[TBL] [Abstract][Full Text] [Related]
13. Co-culture of ovarian cancer stem-like cells with macrophages induced SKOV3 cells stemness via IL-8/STAT3 signaling.
Ning Y; Cui Y; Li X; Cao X; Chen A; Xu C; Cao J; Luo X
Biomed Pharmacother; 2018 Jul; 103():262-271. PubMed ID: 29656182
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cells and macrophages interact through IL-6 to promote inflammatory breast cancer in pre-clinical models.
Wolfe AR; Trenton NJ; Debeb BG; Larson R; Ruffell B; Chu K; Hittelman W; Diehl M; Reuben JM; Ueno NT; Woodward WA
Oncotarget; 2016 Dec; 7(50):82482-82492. PubMed ID: 27756885
[TBL] [Abstract][Full Text] [Related]
15. Breast tumor cell TACE-shed MCSF promotes pro-angiogenic macrophages through NF-κB signaling.
Rego SL; Helms RS; Dréau D
Angiogenesis; 2014 Jul; 17(3):573-85. PubMed ID: 24197832
[TBL] [Abstract][Full Text] [Related]
16. CCL18-mediated down-regulation of miR98 and miR27b promotes breast cancer metastasis.
Lin X; Chen L; Yao Y; Zhao R; Cui X; Chen J; Hou K; Zhang M; Su F; Chen J; Song E
Oncotarget; 2015 Aug; 6(24):20485-99. PubMed ID: 26244871
[TBL] [Abstract][Full Text] [Related]
17. The MyD88 inhibitor TJ-M2010-2 suppresses proliferation, migration and invasion of breast cancer cells by regulating MyD88/GSK-3β and MyD88/NF-κB signalling pathways.
Liu JH; Chen C; Li ZY; Zou ZM; Gao DC; Zhang X; Kuang XW; Sun ZH; Zheng WJ; Zhou P; Sun SR
Exp Cell Res; 2020 Sep; 394(2):112157. PubMed ID: 32610185
[TBL] [Abstract][Full Text] [Related]
18. CCL18 promotes the invasion and metastasis of breast cancer through Annexin A2.
Zhao C; Zheng S; Yan Z; Deng Z; Wang R; Zhang B
Oncol Rep; 2020 Feb; 43(2):571-580. PubMed ID: 31894281
[TBL] [Abstract][Full Text] [Related]
19. Tumor-Associated Macrophages Promote Malignant Progression of Breast Phyllodes Tumors by Inducing Myofibroblast Differentiation.
Nie Y; Chen J; Huang D; Yao Y; Chen J; Ding L; Zeng J; Su S; Chao X; Su F; Yao H; Hu H; Song E
Cancer Res; 2017 Jul; 77(13):3605-3618. PubMed ID: 28512246
[TBL] [Abstract][Full Text] [Related]
20. Leptin promotes breast cancer cell migration and invasion via IL-18 expression and secretion.
Li K; Wei L; Huang Y; Wu Y; Su M; Pang X; Wang N; Ji F; Zhong C; Chen T
Int J Oncol; 2016 Jun; 48(6):2479-87. PubMed ID: 27082857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
